Description

15-Dihydro-13,14-Anhydrovirginiamycin M1 is a chemically modified derivative of the streptogramin antibiotic virginiamycin M1, offering a distinct molecular profile for research and development. This compound is valued for its role as a key intermediate or reference standard in the synthesis and study of novel antimicrobial agents. It is primarily utilized by pharmaceutical R&D laboratories, analytical chemists, and manufacturers in the life sciences sector for method development, quality control, and investigative studies.

Application

• Pharmaceutical Reference Standard: Serves as a critical high-purity standard for the identification and quantification of virginiamycin-related compounds in analytical methods like HPLC and LC-MS.
• Antimicrobial Research Intermediate: Used as a building block or precursor in the research and synthesis of new streptogramin-class antibiotics to combat resistant bacterial strains.
• Biochemical Research: Employed in microbiological and biochemical studies to investigate the structure-activity relationships (SAR) of streptogramins and their mechanisms of action.
• Veterinary Pharmaceutical Development: Acts as a key material in the development and quality assurance of veterinary medicinal products targeting bacterial infections.
• Method Development & Validation: Essential for developing, calibrating, and validating chromatographic and spectroscopic analytical methods in quality control laboratories.

Basic Information

Product Name	15-Dihydro-13,14-Anhydrovirginiamycin M1
CAS No.	118693-64-4
Molecular Formula	C28H35N3O7
Molecular Weight	525.60 g/mol
Synonyms	Virginiamycin M1, 15-Dihydro-13,14-anhydro derivative; 13,14-Anhydro-15-dihydrovirginiamycin M1; Antibiotic M1 derivative; Streptogramin A derivative; (3R,4R,5S,6R,8R,11S,12S,13E,15S)-15-Hydroxy-4,6,11,12-tetramethyl-9-oxo-5,6,8,11,12,14,15,16-octahydro-3H-3,13-epoxypyrido[2,1-f][1,6,10,13]oxatriazacyclooctadecine-2-carboxylic acid; Pristinamycin IIA derivative
EINECS	Contact for details

Quality Control

Our 15-Dihydro-13,14-Anhydrovirginiamycin M1 is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (IR, MS), to ensure it meets exacting standards for research and development use. A detailed Certificate of Analysis (COA) containing batch-specific data is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a desiccated environment to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 5.0%
Residue on Ignition	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.